Voters in Oklahoma will decide whether or not to amend the state's constitution to expand Medicaid; new studies find that nearly 300 children in the United States have contracted a rare inflammatory disorder related to coronavirus disease 2019 (COVID-19); the House of Representatives passed a bill aimed to bolster the Affordable Care Act.
Voters in Oklahoma will head to the polls today to decide whether to expand Medicaid to tens of thousands of low-income residents, the Associated Press reports. If the measure passes, the state would be the first to amend their constitution to reflect the expansion. A constitutional amendment will prevent the Republican legislature from rolling back coverage in the future. Although Idaho, Maine, Nebraska, and Utah all expanded Medicaid through ballot questions, they did so through amending state statutes. Missouri is scheduled to vote on a similar constitutional amendment on August 4.Two new studies published in the New England Journal of Medicine found nearly 300 children in the United States have been infected with a multisystem inflammatory syndrome related to coronavirus disease 2019 (COVID-19). Although most children recovered from the condition, there is currently not enough data to understand long-term or permanent damage. Among the 285 infected children, 6 passed away. The hyperinflammatory syndrome has dermatologic, mucocutaneous, and gastrointestinal manifestations and was associated with cardiac dysfunction in some patients. The Democrat-controlled House of Representatives passed a bill to expand the Affordable Care Act (ACA, also called Obamacare), The Hill reports. The bill would increase the ACA’s subsidies to help individuals afford their premiums and add more funding to increase Medicaid expansion. The move comes as the Trump administration last week asked the Supreme Court to repeal the entire ACA, claiming the elimination of the individual mandate rendered the whole law unconstitutional. Proponents of the bill argue repealing the ACA during a global pandemic would only worsen the country’s health outcomes.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More